Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10BeOne Medicines

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

TISLELIZUMAB-JSGR

Brand Name : TEVIMBRA

Dosage Form : INJECTION;SOLUTION

Dosage Strength : 100MG/10ML

Packaging :

Approval Date :

Application Number : 761232

Regulatory Info :

Registration Country : USA

blank

02

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

islelizumab-jsgr

Brand Name : TEVIMBRA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 10 mg/mL

Packaging :

Approval Date :

Application Number : 761380

Regulatory Info :

Registration Country : USA

blank

03

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

TISLELIZUMAB-JSGR

Brand Name : TEVIMBRA

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 100MG/10ML(10MG/ML)

Packaging :

Approval Date :

Application Number : 761417

Regulatory Info :

Registration Country : USA

blank

04

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Tislelizumab

Brand Name : Tevimbra

Dosage Form : Concentrate for infusion solution, solution

Dosage Strength : 100 mg

Packaging : Vials 1 10ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

05

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Tislelizumab

Brand Name : Tevimbra

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 100mg

Packaging :

Approval Date : 15/09/2023

Application Number : 20220304000085

Regulatory Info : Approved

Registration Country : Sweden

blank

06

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Tislelizumab

Brand Name : Tizveni

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 100mg

Packaging :

Approval Date : 19/04/2024

Application Number : 20220304000054

Regulatory Info : Deregistered

Registration Country : Sweden

blank

07

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Tislelizumabum

Brand Name : Tevimbra

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 100mg/10ml

Packaging :

Approval Date : 11/04/2024

Application Number : 68960

Regulatory Info : Allowed

Registration Country : Switzerland

blank

08

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Tisselizumab

Brand Name : Tevimbra

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 100MG

Packaging :

Approval Date : 2024-07-26

Application Number : 1231758001

Regulatory Info : Authorized

Registration Country : Spain

blank

09

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

tislelizumab

Brand Name : Tevimbra

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

10

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

tislelizumab

Brand Name : Tevimbra

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank